Amarin Corp Plc (AMRN)

[AtlasSnuggled]

TEMP MEMBERS(VOTING) Peter W.F. Wilson, MD
Professor of Medicine Emory University School of Medicine Department of Cardiology Atlanta, Georgia

7. OPERA and FORWARD Death knell for fish oil in atrial fibrillation Results: Short-term administration of fish oil to patients undergoing heart surgery did not reduce the incidence of postoperative atrial fibrillation (AF) according to the results of the OPERA trial. There was no difference between the active- treatment and placebo groups in terms of preventing postoperative AF, despite the fact that patients in this study were given fairly high doses of fish oil in the form of a prescription product. This assertion was borne out in a second trial, Fish Oil Research with Omega-3 for Atrial Fibrillation Recurrence Delay (FORWARD), performed in people with previous AF, to see whether 1 g per day of fish oil would prevent recurrences. It did not. "Every time weve had a major trial using omega-3s that was conducted as a primary purpose of the trial, weve come up short. Its very discouraging for the omega-3 story," said invited panel member Dr Peter Wilson (Emory University, Atlanta). See: OPERA does not sing praises for fish oil in AF

http://www.slideshare.net/theheartorg/aha-2012-research-highlights


http://mobile.reuters.com/article/healthNews/idUSBRE8A413J20121105?irpc=962